Follow Aura Biosciences. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.
3 Stories in coverage 2 Programs 52 recruiting Registered trials Nov 9 Latest story
Timeline 3 Pipeline 2 Trials 5
Pipeline by stage
Phase 2 1 Phase 1 1
Details
Headquarters Boston, MA Incorporated Delaware Industry Biological Products, (No Diagnostic Substances) Also known as AURA, Aura Biosciences, Inc. How the company describes itself Aura Biosciences is a clinical-stage biotechnology company developing bel-sar, a therapy for ocular cancers including choroidal melanoma, metastases to the choroid, and ocular surface cancers. Bel-sar acts through tumor necrosis and anti-tumor immune activation. A Phase 3 study in early choroidal melanoma is fully enrolled. source